Condition 1: cancer. Condition 2: anxiety. Condition 3: depression. Condition 4: somatic complaints. Condition 5: attention problems. Mood disorder due to known physiological condition, unspecified Anxiety disorder due to known physiological condition Mood disorder due to known physiological condition with depressive features Anxiety disorder due to known physiological condition Attention-deficit hyperactivity disorders
Conditions
Interventions
Intervention 1: Forty children (ages 11 to 13) diagnosed with cancer were randomly assigned to either a modified MBCT-C group (n?=?20) or treatment as usual (TAU) control group (n?=?20). To meet the n
Sponsors
Laurentian Universiry
Eligibility
Sex/Gender
All
Age
11 Years to 13 Years
Inclusion criteria
Inclusion criteria: Hospitalized patients were eligible to participate in the Mindfulness-Based Cognitive Therapy for Children (MBCT-C) program in addition to receiving TAU if they were (a) 11 to 13 years of age; (b) had at least average fluency in Persian; (c) had received the first diagnosis of any type of cancer except brain cancers; (d) were undergoing radiation therapy and/or chemotherapy through the hospital’s oncology division; and (e) had not received any psychological interventions or psychiatric medications in the six months preceding the study. Diagnostic inclusion criteria were: (f) a diagnosis of Autism spectrum disorder (ASD) (Diagnostic and Statistical Manual of Mental Disorders (IV) (DSM-IV (American Psychiatric Association, 2000); and (g) at least two comorbid diagnoses in any of four diagnostic categories (anxiety, depression, psychosomatic, or attention deficit disorders). Diagnoses were ascertained using the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Persian version (K-SADS-PL-P). Additionally, patients needed to be: (h) in the borderline or clinical range for internalizing problems (T-score = 60) and attention problems (T-score = 57) on at least two of four subscales of the Child Behavior Checklist (CBCL) or Youth Self-Report (YSR )(depression/anxiety, withdrawal/depression, somatic complaints, and attention problems) at the screening assessment.
Exclusion criteria
Exclusion criteria: Patients who were determined to (i) have a major cognitive dysfunction or developmental disability, or (j) was diagnosed with a terminal illness (defined as having a prognosis of fewer than six months) were excluded. Moreover, Brain cancers were excluded based on research suggesting that these may affect attention (Raghubar et al., 2017), a key outcome variable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Internalizing and attention problems. Timepoint: Before and 4 weeks after the treatment as well as 2-month follow-up. Method of measurement: CBCL and YSR. | — |
Secondary
| Measure | Time frame |
|---|---|
| More cooperation in medical treatments in participants. Timepoint: Before and after the treatment as well as at follow-up point. Method of measurement: Interviews. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactsamaneh abedini najafabadi
Laurentian Universiry
Outcome results
None listed